With Eli Lilly’s Mounjaro entering India, the weight-loss drug race is on. But with steep prices and generics on the way, how ...

Obesity remains a significant public health challenge in the UK, with over 26% of adults classified as obese and an additional 38% considered overweight. This epidemic not only impacts individual ...

It was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks ...

The new generation of weight-loss drugs are a boon for the overweight, but they also promise to change our relationship with ...

Weight loss “wonder drug” Wegovy will cost Irish users around ... As a result, patients will have to pay up to €2,640 a year to access the Wegovy. That is less than the cost of Mounjaro ...

Amy Schumer has praised weight loss drug Mounjaro after a not-so-great experience with Wegovy years prior ... beats Novo Nordisk to major market. (Representative picture: Freepik) In case you ...

the rise in the amount consumed “will be good news for some of the leading ingredient players in the market”. The primary purpose of the new generation of weight-loss drugs is, of course ...

The agreement pertains to Gubra’s experimental weight loss drug ... of the year. Analyst sentiment suggests the stock still has room to run higher. Entering the weight loss market makes sense ...